Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	15.76B -27.3%
Revenue (ttm)	1.17B +30.7%
Net Income	142.15M +6.3%
EPS	0.66 -67.2%
Shares Out	66.76M
PE Ratio	110.84
Forward PE	51.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	439,148
Average Volume	322,546
Open	237.60
Previous Close	236.00
Day's Range	235.40 - 259.80
52-Week Range	165.00 - 346.40
Beta	0.45
RSI	79.26
Earnings Date	Apr 22, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 148
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.